Quantifying HIV-1-specific CD8 (+) T-cell responses using ELISPOT and cytokine flow cytometry

Area of Science:

• Immunology
• Virology
• Infectious Diseases

Background:

• Human immunodeficiency virus (HIV-1), the agent causing AIDS, has been extensively studied to understand host immune responses.
• Identifying correlates of protection is vital for developing effective HIV-1 vaccines and immunotherapies.
• Comparing rapid versus slow disease progression in patients helps define a successful immune response against HIV-1.

Purpose of the Study:

• To elucidate the adaptive, cell-mediated immune response to HIV-1.
• To provide practical protocols for analyzing antigen-specific CD8+ T-cell function.
• To contribute to the understanding of host-pathogen interactions in HIV-1 infection.

Main Methods:

• Utilizing the ELISPOT assay for analyzing antigen-specific CD8+ T-cell function.
• Employing cytokine flow cytometry for detailed assessment of T-cell responses.
• Presenting simple, reproducible protocols for these immunological assays.

Main Results:

• Significant progress has been made in understanding the cell-mediated immune response to HIV-1 over the past two decades.
• New analytical approaches, including ELISPOT and cytokine flow cytometry, have advanced the study of CD8+ T-cell function.
• The provided protocols facilitate the characterization of immune responses crucial for vaccine and immunotherapy development.

Conclusions:

• Despite remaining knowledge gaps, substantial advancements have been achieved in characterizing the adaptive immune response to HIV-1.
• The ELISPOT assay and cytokine flow cytometry are powerful tools for dissecting HIV-1-specific CD8+ T-cell immunity.
• Standardized protocols are essential for consistent and reliable analysis of immune responses, supporting the development of interventions against HIV-1.